Bradford Crutchfield - Jan 12, 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Commercial Officer
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol
TXG
Transactions as of
Jan 12, 2022
Transactions value $
-$2,003,299
Form type
4
Date filed
1/14/2022, 03:32 PM
Previous filing
Dec 23, 2021
Next filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $19.7K +17K +17.41% $1.16 115K Jan 12, 2022 Direct F1
transaction TXG Class A Common Stock Sale -$728K -6.2K -5.4% $117.53 108K Jan 12, 2022 Direct F1, F2
transaction TXG Class A Common Stock Sale -$613K -5.19K -4.78% $118.32 103K Jan 12, 2022 Direct F1, F3
transaction TXG Class A Common Stock Sale -$121K -1.02K -0.98% $119.28 102K Jan 12, 2022 Direct F1, F4
transaction TXG Class A Common Stock Sale -$133K -1.1K -1.08% $120.93 101K Jan 12, 2022 Direct F1, F5
transaction TXG Class A Common Stock Sale -$390K -3.2K -3.16% $121.77 98K Jan 12, 2022 Direct F1, F6
transaction TXG Class A Common Stock Sale -$12.3K -100 -0.1% $122.94 97.9K Jan 12, 2022 Direct F1
transaction TXG Class A Common Stock Sale -$12.4K -100 -0.1% $123.53 97.8K Jan 12, 2022 Direct F1
transaction TXG Class A Common Stock Sale -$12.4K -100 -0.1% $124.44 97.7K Jan 12, 2022 Direct F1
transaction TXG Class A Common Stock Sale -$375 -3 0% $125.00 97.7K Jan 12, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -17K -3.99% $0.00 409K Jan 12, 2022 Class A Common Stock 17K $1.16 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $116.89 to $117.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $117.90 to $118.84. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $118.985 to $119.83. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $120.31 to $121.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $121.47 to $122.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This option, originally for 800,000 shares, of which 391,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.